Literature DB >> 26104990

Plasma soluble corin and N-terminal pro-atrial natriuretic peptide levels in pregnancy induced hypertension.

Moyassar A Zaki1, Salah El-Din S El-Banawy2, Hisham H El-Gammal3.   

Abstract

OBJECTIVE: One of the theories involved in the pathogenesis of pregnancy induced hypertension involves salt and water retention. We aimed to measure the proenzyme convertase corin, responsible for pro-atrial natriuretic peptide (ANP) cleavage to active ANP, in plasma of hypertensive pregnant females. STUDY
DESIGN: Sixty pregnant females suffering from pregnancy induced hypertension in second and third trimesters of pregnancy were compared to twenty eight healthy pregnant females of the same gestational period. Concomitant urine and plasma samples were collected for the determination of some biochemical parameters. Plasma soluble corin and N-terminal (NT) pro-ANP (1-98) values were determined in both groups using enzyme immunoassays.
RESULTS: Plasma soluble corin mean value was significantly higher in the patient group compared to the control group. Upon dividing the patient group according to blood pressure, plasma NT pro-ANP showed significantly higher mean value in the group with blood pressure⩾140/90mmHg compared to the group with blood pressure<140/90mmHg and control group.
CONCLUSIONS: High plasma soluble corin and NT pro-ANP values in hypertensive pregnant females particularly those with blood pressure⩾140/90mmHg speculates an ANP receptor/ post receptor signaling defect, which would aggravate the pregnancy induced hypertensive state.
Copyright © 2011 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  N-terminal pro-atrial natriuretic peptide; Pregnancy induced hypertension; Soluble corin

Year:  2011        PMID: 26104990     DOI: 10.1016/j.preghy.2011.10.001

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  8 in total

Review 1.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

2.  Smoking modifies the effect of two independent SNPs rs5063 and rs198358 of NPPA on central obesity in the Chinese Han population.

Authors:  Huan Zhang; Xingbo Mo; Zhengyuan Zhou; Zhengbao Zhu; Xinfeng Huangfu; Tan Xu; Aili Wang; Zhirong Guo; Yonghong Zhang
Journal:  J Genet       Date:  2018-09       Impact factor: 1.166

3.  Sex-specific association between soluble corin and metabolic syndrome in Chinese adults.

Authors:  Hongmei Li; Qiu Zhang; Yan He; Jijun Shi; Weidong Hu; Hao Peng
Journal:  Hypertens Res       Date:  2019-02-14       Impact factor: 3.872

4.  Circulating NT-proBNP but not soluble corin levels were associated with preeclampsia in pregnancy-associated hypertension.

Authors:  Meera Kumari; Tracy Kovach; Brendan Sheehy; Allyson Zabell; Rommel Morales; Sangithan Jules Moodley; Yogesh G Shah; Praful V Maroo; Anjli P Maroo; W H Wilson Tang
Journal:  Clin Biochem       Date:  2019-03-16       Impact factor: 3.281

Review 5.  Role of corin in the regulation of blood pressure.

Authors:  Hui Li; Yue Zhang; Qingyu Wu
Journal:  Curr Opin Nephrol Hypertens       Date:  2017-03       Impact factor: 2.894

6.  Role of Corin in Blood Pressure Regulation in Normotensive and Hypertensive Pregnancy.

Authors:  Mark B Badrov; Sun Young Park; Jeung-Ki Yoo; Michinari Hieda; Yoshiyuki Okada; Sara S Jarvis; Abigail S Stickford; Stuart A Best; David B Nelson; Qi Fu
Journal:  Hypertension       Date:  2019-02       Impact factor: 10.190

Review 7.  Role of corin and atrial natriuretic peptide in preeclampsia.

Authors:  Y Zhou; Q Wu
Journal:  Placenta       Date:  2012-12-02       Impact factor: 3.481

8.  Association between serum soluble corin and hyperglycaemia: a cross-sectional study among Chinese adults.

Authors:  Yan Liu; Hao Peng; Qiu Zhang; Peipei Zhang; Yunfan Tian; Xiangqin Chao; Yonghong Zhang
Journal:  BMJ Open       Date:  2015-12-23       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.